Vera Therapeutics, Inc.
VERA
$34.18
-$1.10-3.12%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 9.55% | -32.86% | -13.46% | -4.92% | -48.05% |
| Total Depreciation and Amortization | -5.71% | 3.70% | 4.65% | 8.40% | 40.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -44.77% | 165.13% | 10.80% | 16.28% | 23.96% |
| Change in Net Operating Assets | 53.07% | -232.48% | 19.30% | -35.09% | 241.79% |
| Cash from Operations | 5.87% | -52.16% | -13.06% | -12.97% | -0.72% |
| Capital Expenditure | 100.00% | 77.45% | 23.31% | 36.06% | -11.23% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 123.85% | -270.61% | 15.55% | 143.09% | 85.45% |
| Cash from Investing | 123.84% | -270.85% | 15.63% | 144.40% | 86.36% |
| Total Debt Issued | -- | -- | -- | -100.00% | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -51.34% | -98.70% | 38,066.50% | 71.77% | -69.73% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 100.00% | -- |
| Cash from Financing | -51.34% | -98.62% | 35,819.95% | -96.07% | 1,223.22% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 72.76% | -180.95% | 3,332.18% | 244.95% | 84.11% |